Characterization of temporal expressions of FOXO and pFOXO proteins in the hippocampus by kainic acid in mice: involvement of NMDA and non-NMDA receptors

被引:0
作者
Soo-Hyun Park
Yun-Beom Sim
Jin-Koo Lee
Jae-Yong Lee
Hong-Won Suh
机构
[1] Hallym University,Department of Pharmacology, Institute of Natural Medicine, College of Medicine
[2] Seoul National University,#81 Biotechnology Incubating Center, Institute for Stem Cell and Regenerative Medicine in Kangstem Biotech
[3] Dankook University,Department of Pharmacology, College of Medicine
[4] Hallym University,Department of Biochemistry, College of Medicine
来源
Archives of Pharmacal Research | 2016年 / 39卷
关键词
Kainic acid; FoxO; MK-801; CNQX; Hippocampus;
D O I
暂无
中图分类号
学科分类号
摘要
In the present study, we characterized the expression and role of forkhead box O (FoxO3a) in kainic acid (KA)-induced hippocampal neuronal cell death. FoxO3a and pFoxO3a expression in the CA1, CA2, and dentate gyrus regions in the hippocampus increased 0.5 and 1 h after intracerebroventricular administration of KA. In addition, both FoxO3a and pFoxO3a expression in the hippocampal CA3 region increased significantly and equally for 1 h but decreased gradually for 24 h after KA administration. In particular, the KA-induced increases in FoxO3a and pFoxO3a expression in the hippocampal CA3 region were inhibited by pretreatment with the N-methyl-d-aspartate (NMDA) receptor antagonist (MK-801, dizocilpine, 1 µg/5 µl) or a non-NMDA receptor antagonist (CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione, 0.5 µg/5 µl). Furthermore, dizocilpine and CNQX produced a neuroprotective effect against KA-induced neuronal death in the CA3 region of the hippocampus. Our results suggest that FoxO3a and pFoxO3 expression is upregulated by KA. Both FoxO3a and pFoxO3a expression appear to be responsible for KA-induced neuronal death in the CA3 region of the hippocampus.
引用
收藏
页码:660 / 667
页数:7
相关论文
共 146 条
  • [1] Arzimanoglou A(2002)Epilepsy and neuroprotection: an illustrated review Epileptic Disord 4 173-182
  • [2] Hirsch E(2007)FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2 Mol Cell 28 941-953
  • [3] Nehlig A(1992)Mechanisms of excitotoxicity in neurologic diseases FASEB J 6 3338-3344
  • [4] Castelnau P(1984)Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis J Neurochem 43 1369-1374
  • [5] Gressens P(1998)Neuropharmacology of AMPA and kainate receptors Neuropharmacology 37 1187-1204
  • [6] Pereira de Vasconcelos A(1999)Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor Cell 96 857-868
  • [7] Bakker WJ(2001)Selective vulnerability to kainate-induced oxidative damage in different rat brain regions J Appl Toxicol 21 403-407
  • [8] Harris IS(2005)Activating Akt and the brain’s resources to drive cellular survival and prevent inflammatory injury Histol Histopathol 20 299-315
  • [9] Mak TW(2005)Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease Prog Neurobiol 75 207-246
  • [10] Beal MF(2006)Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress Curr Neurovasc Res 3 107-117